The biotech's efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of intellectual-property theft in China. DDN attracts a $300 million infusion ...

Artificial intelligence (AI) stocks have soared over the last couple of years as optimism about the technology and its ...